J.W. Cole Advisors, Inc. Moderna, Inc. Transaction History

J.W. Cole Advisors, Inc.

$2.33 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$101.21 - $166.61 $3,441 - $5,664	34 Added 1.53%	2,261 $268,000
Q1 2024 Apr 30, 2024	BUY	$85.37 - $115.44 $426 - $577	5 Added 0.23%	2,227 $237,000
Q4 2023 Jan 31, 2024	BUY	$69.51 - $104.43 $12,094 - $18,170	174 Added 8.5%	2,222 $220,000
Q3 2023 Oct 24, 2023	SELL	$96.41 - $126.61 $7,423 - $9,748	-77 Reduced 3.62%	2,048 $211,000
Q2 2023 Jul 27, 2023	SELL	$118.5 - $160.53 $41,001 - $55,543	-346 Reduced 14.0%	2,125 $258,000
Q1 2023 May 03, 2023	BUY	$135.66 - $197.02 $19,670 - $28,567	145 Added 6.23%	2,471 $379,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $15,034 - $26,675	-127 Reduced 5.18%	2,326 $417,000
Q3 2022 Oct 31, 2022	SELL	$118.07 - $194.18 $101,304 - $166,606	-858 Reduced 25.91%	2,453 $290,000
Q2 2022 Jul 27, 2022	SELL	$117.13 - $176.59 $170,189 - $256,585	-1,453 Reduced 30.5%	3,311 $473,000
Q1 2022 Jun 10, 2022	SELL	$126.46 - $235.05 $64.2 Million - $119 Million	-507,493 Reduced 99.07%	4,764 $821,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $64.3 Million - $120 Million	508,723 Added 14395.1%	512,257 $322,000
Q4 2021 Jan 25, 2022	SELL	$225.82 - $368.51 $531,354 - $867,104	-2,353 Reduced 39.97%	3,534 $898,000
Q3 2021 Oct 26, 2021	BUY	$221.9 - $484.47 $118,050 - $257,738	532 Added 9.93%	5,887 $2.27 Million
Q2 2021 Aug 06, 2021	SELL	$129.91 - $234.98 $46,118 - $83,417	-355 Reduced 6.22%	5,355 $1.26 Million
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $408,442 - $695,751	3,741 Added 189.99%	5,710 $748,000
Q4 2020 Feb 12, 2021	SELL	$65.74 - $169.86 $96,111 - $248,335	-1,462 Reduced 42.61%	1,969 $206,000
Q3 2020 Nov 05, 2020	BUY	$54.34 - $94.85 $186,440 - $325,430	3,431 New	3,431 $243,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Account